{"disease":{"id":"opioid-use-disorder-moderate","name":"opioid use disorder moderate"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04345718","title":"EXHIT ENTRE Comparative Effectiveness Trial","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":344,"lead_sponsor_name":"Gavin Bart","has_results":false},{"nct_id":"NCT06651177","title":"Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":310,"lead_sponsor_name":"T. John Winhusen, PhD","has_results":false},{"nct_id":"NCT04850664","title":"Computerized Chemosensory-Based Orbitofrontal Cortex (CBOT) for Opioid Use Disorder","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":190,"lead_sponsor_name":"Evon Medics LLC","has_results":false},{"nct_id":"NCT05995873","title":"A Project to Test the Efficacy and Safety of An Innovative Treatment for Opiate Use Disorders.","phase":"NA","overall_status":"UNKNOWN","enrollment_count":130,"lead_sponsor_name":"MindLight, LLC","has_results":false},{"nct_id":"NCT04921787","title":"EXHIT ENTRE Implementation Trial of High Intensity Versus Low Intensity Strategy","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":24,"lead_sponsor_name":"Gavin Bart","has_results":false},{"nct_id":"NCT04060654","title":"SUBLOCADE Rapid Initiation Extension Study","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"Indivior Inc.","has_results":true},{"nct_id":"NCT04982627","title":"A Brief Negotiation Interview Chatbot to Improve Buprenorphine Engagement Among Justice-Involved Individuals","phase":"NA","overall_status":"COMPLETED","enrollment_count":4,"lead_sponsor_name":"Center for Progressive Recovery, LLC","has_results":false},{"nct_id":"NCT05251376","title":"Study of LYN-014 in Individuals With Opioid Use Disorder Who Are Stable on Methadone Therapy","phase":"PHASE1","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Lyndra Inc.","has_results":false}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}